Country: Malta
Language: English
Source: Medicines Authority
TRIAMCINOLONE ACETONIDE
Sanofi Malta Limited
R01AD11
TRIAMCINOLONE ACETONIDE
NASAL SPRAY, SUSPENSION
TRIAMCINOLONE ACETONIDE 55 microgram(s)
POM
NASAL PREPARATIONS
Authorised
2005-11-17
PACKAGE LEAFLET: INFORMATION FOR THE USER 55 MICROGRAMS/DOSE, NASAL SPRAY SUSPENSION Triamcinolone acetonide Is this leaflet hard to see or read? In the UK Phone 0845 372 7101 for help. In the Republic of Ireland Phone 01 4035600 READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. ● Keep this leaflet. You may need to read it again. ● If you have any further questions, ask your doctor or pharmacist. ● This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. ● If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet (see section 4). WHAT IS IN THIS LEAFLET 1. What Nasacort is and what it is used for 2. What you need to know before you use Nasacort 3. How to use Nasacort 4. Possible side effects 5. How to store Nasacort 6. Contents of the pack and other information 1. WHAT NASACORT IS AND WHAT IT IS USED FOR Nasacort contains a medicine called triamcinolone acetonide. This belongs to a group of medicines called corticosteroids which means it is a type of steroid. It is given as a spray in the nose to treat the nasal symptoms of allergic rhinitis. Nasal symptoms of allergy include sneezing, itching, and having a blocked, stuffy or runny nose. These can be caused by things such as: ● Animal fur or house dust mites. This type of allergy can happen at any time of the year and is called ‘perennial allergic rhinitis’. ● Pollen. This type of allergy, such as hay fever, can be caused by different pollens in different seasons of the year. This is called ‘seasonal allergic rhinitis’. This medicine only works if used on a regular basis and may not help your symptoms straight away. It helps some people within the first day of treatment, however, for other people it may take 3 to 4 days to feel a relief. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE NASACORT DO NOT USE NASACORT: ✖ Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Nasacort 55 micrograms/dose, nasal spray, suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Bottles of Nasacort contain either 6.5 g or 16.5 g of suspension (with 3.575 mg or 9.075 mg triamcinolone acetonide, respectively). One delivered dose contains 55 micrograms of triamcinolone acetonide. Excipient with known effect: 15 micrograms of benzalkonium chloride/delivered dose. For the full list of excipients, see 6.1. 3. PHARMACEUTICAL FORM Nasal spray, suspension It is an unscented, off-white, thixotropic suspension of microcrystalline triamcinolone acetonide in an aqueous medium. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nasacort is indicated for the treatment of symptoms of seasonal and perennial allergic rhinitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _PATIENTS AGED 12 YEARS AND OVER:_ The recommended starting dose is 220 micrograms as 2 sprays in each nostril once daily. Once symptoms are controlled patients can be maintained on 110 micrograms (1 spray in each nostril once daily). _PAEDIATRIC PATIENTS AGED 6 TO 12 YEARS:_ The recommended dose is 110 micrograms as 1 spray in each nostril once daily. In patients with more severe symptoms, a dose of 220 micrograms may be used. But once symptoms are controlled, patients should be maintained on the lowest effective dose. (see sections 4.4 and 5.1). Special population _Paediatric population _ Until further evidence is available, continuous use beyond 3 months in children under 12 years is not recommended. PAGE 2 OF 7 Method of administration NASACORT is for nasal use only. It is important to shake the bottle gently before each use. Each actuation delivers 55 micrograms triamcinolone acetonide from the nose piece to the patient (estimated from _in vitro _testing) after an initial priming of 5 sprays until a fine mist is achieved. Nasacort will remain adequately primed for 2 weeks. If the product is unused for more than 2 weeks, then it can be adequately re-primed with one Read the complete document